Everjoy Health Group Co.,Ltd. (SHE:002162)
China · Delayed Price · Currency is CNY 5.50
+0.03 (0.55%)
Feb 13, 2026, 3:04 PM CST
Everjoy Health Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,006 | 1,124 | 1,192 | 1,077 | 1,184 | 1,117 |
Other Revenue | 80.3 | 80.3 | 85.7 | 85.24 | 77 | 77.23 |
| 1,087 | 1,204 | 1,278 | 1,163 | 1,261 | 1,195 | |
Revenue Growth (YoY) | -11.57% | -5.79% | 9.94% | -7.79% | 5.54% | 2.44% |
Cost of Revenue | 863.45 | 961.34 | 1,012 | 972.63 | 927.3 | 867.96 |
Gross Profit | 223.11 | 242.8 | 266.55 | 190 | 333.53 | 326.74 |
Selling, General & Admin | 203.32 | 241.25 | 250.68 | 242.47 | 235.67 | 216.64 |
Research & Development | 7.01 | 7.92 | 10.21 | 11.69 | 13.48 | 13.18 |
Other Operating Expenses | 10.27 | 11.1 | 13.36 | 12.5 | 14.02 | 5.14 |
Operating Expenses | 249.22 | 295.8 | 331.6 | 315.5 | 269.53 | 232.08 |
Operating Income | -26.11 | -52.99 | -65.05 | -125.5 | 64 | 94.66 |
Interest Expense | -21.79 | -23.9 | -27.04 | -30.06 | -34.16 | -37.15 |
Interest & Investment Income | 10.44 | 5.07 | 167.98 | 3.4 | 2.08 | 3.17 |
Currency Exchange Gain (Loss) | 0.06 | 0.06 | -0.02 | 0.04 | -0.02 | -0.13 |
Other Non Operating Income (Expenses) | -0.47 | -1.45 | -22.19 | -28.8 | -0.64 | -2.91 |
EBT Excluding Unusual Items | -37.87 | -73.22 | 53.69 | -180.92 | 31.27 | 57.65 |
Impairment of Goodwill | -17.07 | -17.07 | - | -42.58 | - | -6.65 |
Gain (Loss) on Sale of Investments | -0.59 | -5.84 | -0.73 | -9.87 | 17.51 | 22.87 |
Gain (Loss) on Sale of Assets | 0.26 | 0.28 | -3.16 | -64.01 | -8.2 | -0.55 |
Asset Writedown | -21.21 | -15.9 | -20.56 | -11.49 | - | -5.94 |
Other Unusual Items | 0.33 | 0.33 | 10.18 | 8.03 | 7.21 | -0.37 |
Pretax Income | -76.15 | -111.42 | 39.42 | -300.84 | 47.79 | 67 |
Income Tax Expense | 36.18 | 38.6 | -8.61 | -20.57 | 0.02 | 9.89 |
Earnings From Continuing Operations | -112.33 | -150.02 | 48.03 | -280.27 | 47.77 | 57.11 |
Minority Interest in Earnings | 1.36 | 2.9 | 2.03 | 2.43 | -1.6 | 0.08 |
Net Income | -110.97 | -147.12 | 50.06 | -277.84 | 46.17 | 57.2 |
Net Income to Common | -110.97 | -147.12 | 50.06 | -277.84 | 46.17 | 57.2 |
Net Income Growth | - | - | - | - | -19.27% | 51.02% |
Shares Outstanding (Basic) | 910 | 922 | 927 | 926 | 890 | 854 |
Shares Outstanding (Diluted) | 910 | 922 | 927 | 926 | 890 | 854 |
Shares Change (YoY) | -1.65% | -0.51% | 0.07% | 4.14% | 4.21% | 0.08% |
EPS (Basic) | -0.12 | -0.16 | 0.05 | -0.30 | 0.05 | 0.07 |
EPS (Diluted) | -0.12 | -0.16 | 0.05 | -0.30 | 0.05 | 0.07 |
EPS Growth | - | - | - | - | -22.54% | 50.90% |
Free Cash Flow | 39.8 | 50.61 | 74.1 | -13.63 | 119.09 | 123.42 |
Free Cash Flow Per Share | 0.04 | 0.06 | 0.08 | -0.01 | 0.13 | 0.14 |
Gross Margin | 20.53% | 20.16% | 20.85% | 16.34% | 26.45% | 27.35% |
Operating Margin | -2.40% | -4.40% | -5.09% | -10.79% | 5.08% | 7.92% |
Profit Margin | -10.21% | -12.22% | 3.92% | -23.90% | 3.66% | 4.79% |
Free Cash Flow Margin | 3.66% | 4.20% | 5.80% | -1.17% | 9.45% | 10.33% |
EBITDA | 5.7 | -15.46 | -19.89 | -68.86 | 124.46 | 155.73 |
EBITDA Margin | 0.52% | -1.28% | -1.56% | -5.92% | 9.87% | 13.04% |
D&A For EBITDA | 31.81 | 37.53 | 45.16 | 56.64 | 60.46 | 61.06 |
EBIT | -26.11 | -52.99 | -65.05 | -125.5 | 64 | 94.66 |
EBIT Margin | -2.40% | -4.40% | -5.09% | -10.79% | 5.08% | 7.92% |
Effective Tax Rate | - | - | - | - | 0.04% | 14.76% |
Revenue as Reported | 1,087 | 1,204 | 1,278 | 1,163 | 1,261 | 1,195 |
Advertising Expenses | - | 31.93 | 32.69 | 30.32 | 27.56 | 21.64 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.